Laryngitis after inhalation of liposomal amikacin

Atsuho Morita; Ho Namkoong; Makoto Hosoya; Naoki Hasegawa

doi:10.1002/ccr3.5350

Clinical Case Reports (Feb 2022)

Laryngitis after inhalation of liposomal amikacin

Atsuho Morita,
Ho Namkoong,
Makoto Hosoya,
Naoki Hasegawa

Affiliations

Atsuho Morita: Division of Pulmonary Medicine, Department of Medicine Keio University School of Medicine Tokyo Japan
Ho Namkoong: Department of Infectious Diseases Keio University School of Medicine Tokyo Japan
Makoto Hosoya: Department of Otorhinolaryngology, Head and Neck Surgery Keio University School of Medicine Tokyo Japan
Naoki Hasegawa: Department of Infectious Diseases Keio University School of Medicine Tokyo Japan

DOI: https://doi.org/10.1002/ccr3.5350
Journal volume & issue: Vol. 10, no. 2
pp. n/a – n/a

Abstract

Read online

Abstract A 56‐year‐old woman with pulmonary Mycobacterium avium complex disease was started on inhalation liposomal amikacin. One month later, she developed hoarseness and was diagnosed with laryngitis. The laryngitis healed immediately after treatment discontinuation, and no recurrence occurred even after resuming intermittent inhalation.

Published in Clinical Case Reports

ISSN: 2050-0904 (Online)
Publisher: Wiley
Country of publisher: United Kingdom
LCC subjects: Medicine: Medicine (General)
Website: https://onlinelibrary.wiley.com/journal/20500904

About the journal

Abstract

Keywords